Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 250

1.

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.

Bursill D, Taylor WJ, Terkeltaub R, Abhishek A, So AK, Vargas-Santos AB, Gaffo AL, Rosenthal A, Tausche AK, Reginato A, Manger B, Sciré C, Pineda C, van Durme C, Lin CT, Yin C, Albert DA, Biernat-Kaluza E, Roddy E, Pascual E, Becce F, Perez-Ruiz F, Sivera F, Lioté F, Schett G, Nuki G, Filippou G, McCarthy G, da Rocha Castelar Pinheiro G, Ea HK, Tupinambá HA, Yamanaka H, Choi HK, Mackay J, ODell JR, Vázquez Mellado J, Singh JA, Fitzgerald JD, Jacobsson LTH, Joosten L, Harrold LR, Stamp L, Andrés M, Gutierrez M, Kuwabara M, Dehlin M, Janssen M, Doherty M, Hershfield MS, Pillinger M, Edwards NL, Schlesinger N, Kumar N, Slot O, Ottaviani S, Richette P, MacMullan PA, Chapman PT, Lipsky PE, Robinson P, Khanna PP, Gancheva RN, Grainger R, Johnson RJ, Te Kampe R, Keenan RT, Tedeschi SK, Kim S, Choi SJ, Fields TR, Bardin T, Uhlig T, Jansen T, Merriman T, Pascart T, Neogi T, Klück V, Louthrenoo W, Dalbeth N.

Ann Rheum Dis. 2019 Nov;78(11):1592-1600. doi: 10.1136/annrheumdis-2019-215933. Epub 2019 Sep 9.

PMID:
31501138
2.

Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.

Pascart T, Norberciak L, Ea HK, Graf S, Guggenbuhl P, Lioté F.

Rheumatology (Oxford). 2019 Dec 1;58(12):2181-2187. doi: 10.1093/rheumatology/kez203.

PMID:
31177284
3.

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castaneda J, Coyfish M, Guillo S, Jansen T, Janssens H, Lioté F, Mallen CD, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell A, So AK, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2019 Jun 5. pii: annrheumdis-2019-215315. doi: 10.1136/annrheumdis-2019-215315. [Epub ahead of print]

PMID:
31167758
4.

Adsorption of Proteins on m-CPPD and Urate Crystals Inhibits Crystal-induced Cell Responses: Study on Albumin-crystal Interaction.

Renaudin F, Sarda S, Campillo-Gimenez L, Séverac C, Léger T, Charvillat C, Rey C, Lioté F, Camadro JM, Ea HK, Combes C.

J Funct Biomater. 2019 Apr 25;10(2). pii: E18. doi: 10.3390/jfb10020018.

5.

Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy.

Perez-Ruiz F, Jansen TL, Tausche AK, Richette P, Lioté F, So AK, Stack A.

Rheumatol Ther. 2019 Mar;6(1):101-108. doi: 10.1007/s40744-019-0143-9. Epub 2019 Feb 14.

6.

Management of immune-related adverse events resulting from immune checkpoint blockade.

Baroudjian B, Arangalage D, Cuzzubbo S, Hervier B, Lebbé C, Lorillon G, Tazi A, Zalcman G, Bouattour M, Lioté F, Gautier JF, Brosseau S, Lourenco N, Delyon J; PATIO group.

Expert Rev Anticancer Ther. 2019 Mar;19(3):209-222. doi: 10.1080/14737140.2019.1562342. Epub 2019 Jan 9.

PMID:
30572735
7.

Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.

Campillo-Gimenez L, Renaudin F, Jalabert M, Gras P, Gosset M, Rey C, Sarda S, Collet C, Cohen-Solal M, Combes C, Lioté F, Ea HK.

Front Immunol. 2018 Oct 9;9:2248. doi: 10.3389/fimmu.2018.02248. eCollection 2018.

8.

Reply to the comment of Mourgues et al., 2012. American guidelines for the management of gout as seen by general practitioners.

Goossens J, Lancrenon S, Lanz S, Ea HK, Lambert C, Guggenbuhl P, Saraux A, Delva C, Sahbane S, Lioté F.

Joint Bone Spine. 2019 Mar;86(2):279-280. doi: 10.1016/j.jbspin.2018.09.018. Epub 2018 Oct 3. No abstract available.

9.

Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study.

Ebstein E, Forien M, Norkuviene E, Richette P, Mouterde G, Daien C, Ea HK, Brière C, Lioté F, Petraitis M, Bardin T, Ora J, Dieudé P, Ottaviani S.

Rheumatology (Oxford). 2019 Mar 1;58(3):410-417. doi: 10.1093/rheumatology/key303.

PMID:
30285127
10.

Cross-sectional survey of the undergraduate rheumatology curriculum in European medical schools: a EULAR School of Rheumatology initiative.

Abhishek A, Iagnocco A, Bijlsma JWJ, Doherty M, Lioté F.

RMD Open. 2018 Sep 21;4(2):e000743. doi: 10.1136/rmdopen-2018-000743. eCollection 2018.

11.

Reply.

Sène D, Ismael S, Forien M, Dieudé P, Charlotte F, Cacoub P, Kaci R, Diallo A, Lioté F.

Arthritis Rheumatol. 2019 Jan;71(1):171-172. doi: 10.1002/art.40714. Epub 2018 Nov 24. No abstract available.

PMID:
30182519
12.

Osteopenia and fractures associated with long-term therapy with MEK inhibitors.

Dumas M, Laly P, Gottlieb J, Vercellino L, Paycha F, Bagot M, Baroudjian B, Madelaine I, Basset-Seguin N, Eftekhari P, Pagès C, Lebbé C, Lioté F.

Melanoma Res. 2018 Dec;28(6):641-644. doi: 10.1097/CMR.0000000000000490.

PMID:
30124538
13.

Non-pharmacologic measures for gout management in the prospective GOSPEL cohort: Physicians' practice and patients' compliance profiles.

Chapron A, Chopin T, Esvan M, Ea HK, Lioté F, Guggenbuhl P.

Joint Bone Spine. 2019 Mar;86(2):225-231. doi: 10.1016/j.jbspin.2018.06.013. Epub 2018 Jul 17.

14.

Patients With Early-Onset Gout and Development of Earlier Severe Joint Involvement and Metabolic Comorbid Conditions: Results From a Cross-Sectional Epidemiologic Survey.

Pascart T, Norberciak L, Ea HK, Guggenbuhl P, Lioté F.

Arthritis Care Res (Hoboken). 2019 Jul;71(7):986-992. doi: 10.1002/acr.23706. Epub 2019 Jun 12.

15.

From hyperuricaemia to gout: what are the missing links?

Lioté F, Pascart T.

Nat Rev Rheumatol. 2018 Aug;14(8):448-449. doi: 10.1038/s41584-018-0040-6. No abstract available.

PMID:
29921940
16.

Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.

Bursill D, Taylor WJ, Terkeltaub R, Kuwabara M, Merriman TR, Grainger R, Pineda C, Louthrenoo W, Edwards NL, Andrés M, Vargas-Santos AB, Roddy E, Pascart T, Lin CT, Perez-Ruiz F, Tedeschi SK, Kim SC, Harrold LR, McCarthy G, Kumar N, Chapman PT, Tausche AK, Vazquez-Mellado J, Gutierrez M, da Rocha Castelar-Pinheiro G, Richette P, Pascual E, Fisher MC, Burgos-Vargas R, Robinson PC, Singh JA, Jansen TL, Saag KG, Slot O, Uhlig T, Solomon DH, Keenan RT, Scire CA, Biernat-Kaluza E, Dehlin M, Nuki G, Schlesinger N, Janssen M, Stamp LK, Sivera F, Reginato AM, Jacobsson L, Lioté F, Ea HK, Rosenthal A, Bardin T, Choi HK, Hershfield MS, Czegley C, Choi SJ, Dalbeth N.

Arthritis Care Res (Hoboken). 2019 Mar;71(3):427-434. doi: 10.1002/acr.23607.

PMID:
29799677
17.

Gout furonculosis.

Lioté F.

Joint Bone Spine. 2019 Jan;86(1):103. doi: 10.1016/j.jbspin.2018.05.002. Epub 2018 May 19. No abstract available.

PMID:
29787811
18.

Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.

Sène D, Ismael S, Forien M, Charlotte F, Kaci R, Cacoub P, Diallo A, Dieudé P, Lioté F.

Arthritis Rheumatol. 2018 Sep;70(9):1481-1488. doi: 10.1002/art.40528. Epub 2018 Jul 29.

19.

Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study.

Loustau C, Rosine N, Forien M, Ottaviani S, Juge PA, Lioté F, Bardin T, Richette P, Dieudé P, Richez C, Bannwarth B, Schaeverbeke T, Ea HK, Truchetet ME.

Joint Bone Spine. 2018 Dec;85(6):755-760. doi: 10.1016/j.jbspin.2018.03.015. Epub 2018 Apr 11.

PMID:
29654950
20.

Gout: state of the art after a decade of developments.

Pascart T, Lioté F.

Rheumatology (Oxford). 2019 Jan 1;58(1):27-44. doi: 10.1093/rheumatology/key002. Review.

PMID:
29547895
21.

Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'.

Audureau E, Roux F, Lons Danic D, Bagot M, Cantagrel A, Dernis E, Gouyette N, Hilliquin P, Jullien D, Lioté F, Passeron T, A Richard M, Claudepierre P.

J Eur Acad Dermatol Venereol. 2018 Nov;32(11):1950-1953. doi: 10.1111/jdv.14861. Epub 2018 Mar 9.

PMID:
29430720
22.

Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN).

Dalbeth N, Bardin T, Doherty M, Lioté F, Richette P, Saag KG, So AK, Stamp LK, Choi HK, Terkeltaub R.

Nat Rev Rheumatol. 2017 Sep;13(9):561-568. doi: 10.1038/nrrheum.2017.126. Epub 2017 Aug 10. Review.

PMID:
28794514
23.

Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study.

Maravic M, Hincapie N, Pilet S, Flipo RM, Lioté F.

Joint Bone Spine. 2018 May;85(3):311-315. doi: 10.1016/j.jbspin.2017.03.013. Epub 2017 May 4.

PMID:
28478208
24.

Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.

Gauci ML, Baroudjian B, Laly P, Madelaine I, Da Meda L, Vercellino L, Bagot M, Lioté F, Pages C, Lebbé C.

Semin Arthritis Rheum. 2017 Oct;47(2):281-287. doi: 10.1016/j.semarthrit.2017.03.003. Epub 2017 Mar 8.

PMID:
28438383
25.

GOSPEL 3: Management of gout by primary-care physicians and office-based rheumatologists in France in the early 21st century - comparison with 2006 EULAR Recommendations.

Goossens J, Lancrenon S, Lanz S, Ea HK, Lambert C, Guggenbuhl P, Saraux A, Delva C, Sahbane S, Lioté F.

Joint Bone Spine. 2017 Jul;84(4):447-453. doi: 10.1016/j.jbspin.2017.04.002. Epub 2017 Apr 12.

PMID:
28411137
26.

Reply to the comment of Daron et al. entitled "Occurrence of rheumatic symptoms in celiac disease: A meta-analysis".

Dos Santos S, Lioté F.

Joint Bone Spine. 2017 Oct;84(5):647-648. doi: 10.1016/j.jbspin.2017.03.007. Epub 2017 Mar 24. No abstract available.

PMID:
28347709
27.

Percutaneous sacroplasty for sacral fracture by osteoporotic insufficiency.

Lioté F, Laredo JD.

Joint Bone Spine. 2017 Jul;84(4):489. doi: 10.1016/j.jbspin.2016.11.009. Epub 2016 Dec 5. No abstract available.

PMID:
27932201
28.

Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.

Juge PA, Truchetet ME, Pillebout E, Ottaviani S, Vigneau C, Loustau C, Cornec D, Pascart T, Snanoudj R, Bailly F, Cornec-Le Gall E, Schaeverbeke T, Saraux A, Dieudé P, Flipo RM, Richette P, Lioté F, Bardin T, Chalès G, Ea HK.

Joint Bone Spine. 2017 Oct;84(5):595-598. doi: 10.1016/j.jbspin.2016.09.020. Epub 2016 Nov 4.

PMID:
27825577
29.

Osteoarticular manifestations of celiac disease and non-celiac gluten hypersensitivity.

Dos Santos S, Lioté F.

Joint Bone Spine. 2017 May;84(3):263-266. doi: 10.1016/j.jbspin.2016.09.007. Epub 2016 Nov 4. Review.

PMID:
27825568
30.

Body mass index and response to abatacept in rheumatoid arthritis.

Gardette A, Ottaviani S, Sellam J, Berenbaum F, Lioté F, Fautrel B, Palazzo E, Meyer A, Sibilia J, Dieudé P.

Eur J Clin Invest. 2016 Dec;46(12):1048-1052. doi: 10.1111/eci.12691. Epub 2016 Nov 7.

PMID:
27736006
31.

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P.

JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512.

PMID:
27654603
32.

2016 updated EULAR evidence-based recommendations for the management of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Lioté F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25. Review.

PMID:
27457514
33.

A Phase III, Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis: Results of the PALACE 2 Trial.

Cutolo M, Myerson GE, Fleischmann RM, Lioté F, Díaz-González F, Van den Bosch F, Marzo-Ortega H, Feist E, Shah K, Hu C, Stevens RM, Poder A.

J Rheumatol. 2016 Sep;43(9):1724-34. doi: 10.3899/jrheum.151376. Epub 2016 Jul 15.

PMID:
27422893
34.

Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis.

Nasi S, Ea HK, Lioté F, So A, Busso N.

PLoS One. 2016 Jul 8;11(7):e0158196. doi: 10.1371/journal.pone.0158196. eCollection 2016.

35.

Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Rasheed H, Phipps-Green AJ, Topless R, Smith MD, Hill C, Lester S, Rischmueller M, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, van Rij A, Jones GT, McCormick SP, Harrison AA, Stamp LK, Dalbeth N, Merriman TR.

Rheumatology (Oxford). 2016 Aug;55(8):1421-30. doi: 10.1093/rheumatology/kew057. Epub 2016 Apr 18.

36.

New therapeutic approach to hyperuricemia and gout in the light of recommendations.

Lioté F.

Joint Bone Spine. 2016 Jul;83(4):376-80. doi: 10.1016/j.jbspin.2016.02.012. Epub 2016 Apr 13. No abstract available.

PMID:
27085801
37.

GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.

Pascart T, Lancrenon S, Lanz S, Delva C, Guggenbuhl P, Lambert C, Aubert JP, Saraux A, Ea HK, Lioté F.

Joint Bone Spine. 2016 Dec;83(6):687-693. doi: 10.1016/j.jbspin.2015.10.006. Epub 2016 Feb 23.

PMID:
26919801
38.

Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.

Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N; PLUS group.

Lupus. 2016 Jun;25(7):735-40. doi: 10.1177/0961203315627200. Epub 2016 Feb 13.

PMID:
26876692
39.

The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.

Rasheed H, McKinney C, Stamp LK, Dalbeth N, Topless RK, Day R, Kannangara D, Williams K, Smith M, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, Lu L, Stahl EA, Choi HK, So A, Merriman TR.

PLoS One. 2016 Jan 25;11(1):e0147939. doi: 10.1371/journal.pone.0147939. eCollection 2016.

40.

Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.

Gardette A, Ottaviani S, Sellam J, Berenbaum F, Lioté F, Meyer A, Sibilia J, Fautrel B, Palazzo E, Dieudé P.

Clin Rheumatol. 2016 Apr;35(4):857-61. doi: 10.1007/s10067-016-3183-3. Epub 2016 Jan 22.

PMID:
26801332
41.

Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.

McKinney C, Stamp LK, Dalbeth N, Topless RK, Day RO, Kannangara DR, Williams KM, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, Merriman TR.

Arthritis Res Ther. 2015 Oct 13;17:288. doi: 10.1186/s13075-015-0802-3.

42.

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ.

Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Erratum in: Ann Rheum Dis. 2016 Feb;75(2):473.

43.

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ.

Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Erratum in: Arthritis Rheumatol. 2016 Feb;68(2):515. Vaquez-Mellado, Janitzia [corrected to Vazquez-Mellado, Janitzia].

44.

Prevalence of Gout in the Adult Population of France.

Bardin T, Bouée S, Clerson P, Chalès G, Flipo RM, Lioté F, Perez V, Poiraud T, Schaeverbeke T, Richette P.

Arthritis Care Res (Hoboken). 2016 Feb;68(2):261-6. doi: 10.1002/acr.22660.

45.

Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.

Jallouli M, Galicier L, Zahr N, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Blanchet B, Hulot JS, Amoura Z, Piette JC, Costedoat-Chalumeau N; Plaquenil Lupus Systemic Study Group.

Arthritis Rheumatol. 2015 May;67(8):2176-84. doi: 10.1002/art.39194.

46.

Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Schoindre Y, Jallouli M, Tanguy ML, Ghillani P, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Hulot JS, Lechat P, Musset L, Piette JC, Amoura Z, Souberbielle JC, Costedoat-Chalumeau N; Group PLUS.

Lupus Sci Med. 2014 Jun 7;1(1):e000027. doi: 10.1136/lupus-2014-000027. eCollection 2014.

47.

Bone status and fractures in 85 adults with Wilson's disease.

Quemeneur AS, Trocello JM, Ea HK, Ostertag A, Leyendecker A, Duclos-Vallée JC, de Vernejoul MC, Woimant F, Lioté F.

Osteoporos Int. 2014 Nov;25(11):2573-80. doi: 10.1007/s00198-014-2806-2. Epub 2014 Jul 16.

PMID:
25027110
48.

Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.

Richette P, Clerson P, Bouée S, Chalès G, Doherty M, Flipo RM, Lambert C, Lioté F, Poiraud T, Schaeverbeke T, Bardin T.

Ann Rheum Dis. 2015 Sep;74(9):1684-90. doi: 10.1136/annrheumdis-2013-204976. Epub 2014 May 5.

PMID:
24796335
49.

Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis.

Nasi S, Ea HK, Chobaz V, van Lent P, Lioté F, So A, Busso N.

Joint Bone Spine. 2014 Jul;81(4):320-4. doi: 10.1016/j.jbspin.2014.01.018. Epub 2014 Apr 2.

PMID:
24703622
50.

Diagnosis and clinical manifestations of calcium pyrophosphate and basic calcium phosphate crystal deposition diseases.

Ea HK, Lioté F.

Rheum Dis Clin North Am. 2014 May;40(2):207-29. doi: 10.1016/j.rdc.2014.01.011. Epub 2014 Mar 4. Review.

PMID:
24703344

Supplemental Content

Support Center